NLRP3 and pulmonary arterial hypertension: Moreover, NLRP3 is a receptor in innate immune cells activated in both PAH rats and hypoxia-stimulated PMECs; it was markedly abolished by administration of phoenixin-20, implying the involvement of NLRP3 inhibition in SIRT1 function against PH (Figure 2) [157,158].